Boston Scientific BSX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 275%+0.5pp | 274.5%+0.4pp | 274.1%-0.4pp | 274.5%-0.7pp | 275.2%-0.6pp | |
| Operating margin | 71.3%+2.2pp | 69.1%+2.5pp | 66.7%+2.1pp | 64.6%+0.8pp | 63.8%-0.5pp | |
| Net margin | 59.6%+5.7pp | 53.8%+3.4pp | 50.4%+3.2pp | 47.3%+1.5pp | 45.8%-0.5pp | |
| EBITDA margin | 99%+1.6pp | 97.4%+1.7pp | 95.7%+1.3pp | 94.4%-0.2pp | 94.5%-1.4pp | |
| Free cash flow margin | 73.7%-0.3pp | 74%+2.4pp | 71.6%+6.2pp | 65.4%+6.8pp | 58.6%+5.6pp | |
| Returns | ||||||
| Return on equity | 51.7%+5.2pp | 46.5%+3.6pp | 42.9%+3.6pp | 39.3%+2.2pp | 37.1%+0.2pp | |
| Return on assets | 28.6%+3.2pp | 25.5%+2.0pp | 23.5%+1.9pp | 21.5%+1.2pp | 20.3%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×0.0× | 1.9×0.0× | 1.9×0.0× | 1.8×0.0× | 1.8×0.0× | |
| Inventory turnover | 8.6×+0.1× | 8.5×+0.2× | 8.3×+0.2× | 8.1×+0.2× | 7.9×+0.1× | |
| Liquidity | ||||||
| Current ratio | 6.4×+0.4× | 5.9×+0.5× | 5.4×0.0× | 5.4×-0.2× | 5.6×-0.2× | |
| Quick ratio | 4.1×+0.3× | 3.7×+0.4× | 3.3×-0.1× | 3.4×-0.3× | 3.7×-0.3× | |
| Cash ratio | 0.6×+0.1× | 0.5×+0.1× | 0.4×0.0× | 0.3×-0.1× | 0.4×0.0× | |
| Leverage | ||||||
| Interest coverage | 40.7×+1.7× | 39×+1.8× | 37.2×+1.6× | 35.7×+0.6× | 35.1×-0.2× | |
| Per Share | ||||||
| Book value per share | $64.17+3.9% | $61.74+2.6% | $60.18+2.9% | $58.46+2.2% | $57.18+2.6% | |
| Valuation | ||||||
| Market capitalization | $533.31B-9.5% | $589.26B+1.7% | $579.55B+3.8% | $558.3B+7.9% | $517.48B+10.4% | |
| Price / earnings | 188.7×-47.5× | 236.2×-22.5× | 258.7×-17.1× | 275.8×-0.4× | 276.2×+16.9× | |
| Price / sales | 27.4×-4.0× | 31.3×-0.8× | 32.2×-0.3× | 32.4×+0.9× | 31.6×+1.7× | |
| Price / book | 22.5×-3.1× | 25.6×-0.2× | 25.8×+0.2× | 25.6×+1.3× | 24.3×+1.7× | |
| Free cash flow yield | 11.2%+1.7pp | 9.5%+0.6pp | 8.9%+0.9pp | 8%+0.6pp | 7.4%+0.3pp | |
| Earnings yield | 9.4%+2.5pp | 6.9%+0.6pp | 6.3%+0.5pp | 5.8%0.0pp | 5.8%-0.4pp | |
| PEG ratio | 3.8×-4.8× | 8.6×-3.6× | 12.3×-0.6× | 12.8×+1.0× | 11.8×+4.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's profit margins?
- Boston Scientific (BSX) runs a 69.2% gross margin and a 18.4% operating margin, with a 17.3% net margin.
- Where do Boston Scientific's ratios come from?
- Every ratio is computed from Boston Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
